Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13.1K Hold
156
﹤0.01% 183
2025
Q2
$12.3K Buy
156
+13
+9% +$1.03K ﹤0.01% 202
2025
Q1
$12.8K Sell
143
-728
-84% -$68K 0.01% 212
2024
Q4
$86.6K Buy
871
+730
+518% +$75.3K 0.03% 101
2024
Q3
$16K Sell
141
-41
-23% -$4.87K 0.01% 237
2024
Q2
$22.5K Sell
182
-3
-2% -$386 0.01% 200
2024
Q1
$24.4K Sell
185
-336
-64% -$41.4K 0.01% 199
2023
Q4
$56.8K Buy
+521
New +$54.1K 0.02% 155

Other funds holding MRK

Pineridge Advisors's MRK Position: Q3 2025 in Review

Pineridge Advisors held its Merck (MRK) position steady in Q3 2025 at 156 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #183.

Pineridge Advisors first reported a position in MRK in Q4 2023 and has held it in 8 quarters since. The position peaked at $86.6K in Q4 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Pineridge Advisors held 156 shares of Merck worth $13.1K as of Q3 2025.
  • Pineridge Advisors left its Merck share count unchanged in Q3 2025.
  • Merck made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #183 holding.
  • Pineridge Advisors first reported a position in Merck in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's Merck position peaked at $86.6K in Q4 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.